Want to join the conversation?
$CERN 2Q15 Call: While we’re disappointed that we were below our guided levels of revenue, our continued levels of strong bookings & positive outlook setup a good 2H15. Our revenue backlog ended the quarter at $13.3Bil, which is up from $9.7Bil a year ago and reflects the strong bookings in 2Q15 and the inclusion of backlog from Health Services.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)